CASP1, caspase 1, 834

N. diseases: 444; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE Tg26<sup>+/-</sup>/ApoE<sup>-/-</sup> have accelerated atherosclerosis with increased caspase-1 pathway activation in inflammatory monocytes and atherosclerotic vasculature compared with ApoE<sup>-/-</sup>. 31315440 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE We conclude that ER stress plays a significant role in endothelial dysfunction of resistance arteries in atherosclerosis and that exercise attenuates ER stress and regulates its critical downstream signaling pathways including eNOS, UCP-2 and caspase-1. 29784903 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE We conclude that alcohol-induced accumulation and crystallization of cholesterol activates NLRP3/caspase-1 in the cerebral vessel that leads to early development of atherosclerosis. 28232172 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 AlteredExpression disease BEFREE The results indicated that the atherosclerosis group significantly decreased miR-22 expression but increased NLRP3 and caspase-1 mRNA and protein expression. 28992621 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE Although the mechanisms had been unclear, emerging evidence unveiled that NLRP3 inflammasomes, which regulate caspase-1 activation and subsequent processing of pro-IL-1β, trigger vascular wall inflammatory responses and lead to progression of atherosclerosis. 28260724 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE Using biochemical, immunologic, pathological, and bone marrow transplantation methods together with the generation of new apoplipoprotein E (ApoE)(-/-)/caspase-1(-/-) double knockout mice, we made the following observations: (1) early hyperlipidemia induced caspase-1 activation in ApoE(-/-) mouse aorta; (2) caspase-1(-/-)/ApoE(-/-) mice attenuated early atherosclerosis; (3) caspase-1(-/-)/ApoE(-/-) mice had decreased aortic expression of proinflammatory cytokines and attenuated aortic monocyte recruitment; and (4) caspase-1(-/-)/ApoE(-/-) mice had decreased EC activation, including reduced adhesion molecule expression and cytokine secretion. 25705917 2015
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 AlteredExpression disease BEFREE Excessive activation of caspase-1 is the underlying cause for rare diseases such as periodic fever syndromes, and more common disorders, including atherosclerosis, type 2 diabetes, and gout. 26059719 2015
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.080 Biomarker disease BEFREE Immunization with native p45 and p210 reduced atherosclerosis by 66% (P < 0.02) and 59% (P = 0.06), respectively. 18783480 2008